This inventor holds 1 USPTO granted patent and 5 published patent applications and 2 EPO patents. Top assignee: Chinese Academy of Sciences. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Shuanggang Ma: Innovator in Gastric Ulcer Treatment
Introduction
Shuanggang Ma is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gastric ulcers. His innovative work has led to the development of a unique extract that shows promise in addressing acid-related diseases.
Latest Patents
Shuanggang Ma holds 1 patent related to his invention. The patent discloses an extract used in the preparation of a drug for the treatment of gastric ulcers. Specifically, it details an extract from the Osbeck Merr plant and its preparation method, which includes the stems and bark being successively grounded, extracted, concentrated, and purified. The pharmaceutical composition derived from this extract has demonstrated strong inhibition activity against proton pumps, making it effective for treating gastric ulcers, chronic gastritis, and other acid-related diseases. The anti-ulcer effect of this extract is significant, quick, safe, and reliable.
Career Highlights
Shuanggang Ma has worked with prestigious institutions such as the Chinese Academy of Sciences and the Chinese Academy of Medical Sciences. His research and development efforts have contributed to advancements in medical treatments and have positioned him as a key figure in his field.
Collaborations
Some of his notable coworkers include Shishan Yu and Jianjun Zhang. Their collaborative efforts have further enhanced the research and development of innovative solutions in the pharmaceutical industry.
Conclusion
Shuanggang Ma's contributions to the treatment of gastric ulcers through his innovative extract highlight his role as a significant inventor in the pharmaceutical field. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
